Why Is Marvell Stock Up?
Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…
Sell
32
FTXH Quote, Financials, Valuation and Earnings
Last price:
$27.04
Seasonality move
:
-0.71%
Day range:
$27.01 - $27.16
52-week range:
$25.73 - $29.72
Dividend yield:
1.65%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.3K
Avg. volume:
--
1-year change:
-1.16%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
$27.14 | -- | -- | -- | $0.13 | 1.65% | -- |
|
BBH
VanEck Biotech ETF
|
$160.63 | -- | -- | -- | $1.25 | 0.78% | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
$106.66 | -- | -- | -- | $0.09 | 0.41% | -- |
|
IHF
iShares US Healthcare Providers ETF
|
$49.71 | -- | -- | -- | $0.10 | 0.83% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$83.58 | -- | -- | -- | $0.22 | 0.96% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$30.05 | -- | -- | -- | $0.06 | 0.69% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | 0.995 | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | 0.969 | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | 1.264 | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | 1.647 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.821 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 1.245 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FTXH
First Trust Nasdaq Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
BBH
VanEck Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
FXH
First Trust Health Care AlphaDEX Fund
|
-- | -- | -- | -- | -- | -- |
|
IHF
iShares US Healthcare Providers ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
First Trust Nasdaq Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns FTXH or BBH?
VanEck Biotech ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat VanEck Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- BBHVanEck Biotech ETF-- -- -- -
What do Analysts Say About FTXH or BBH?
First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than VanEck Biotech ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than VanEck Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 BBHVanEck Biotech ETF0 0 0 -
Is FTXH or BBH More Risky?
First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, which suggesting that the stock is 33.633% less volatile than S&P 500. In comparison VanEck Biotech ETF has a beta of 0.738, suggesting its less volatile than the S&P 500 by 26.201%.
-
Which is a Better Dividend Stock FTXH or BBH?
First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. VanEck Biotech ETF offers a yield of 0.78% to investors and pays a quarterly dividend of $1.25 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. VanEck Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FTXH or BBH?
First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than VanEck Biotech ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than VanEck Biotech ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while VanEck Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for VanEck Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -- BBHVanEck Biotech ETF-- -- -- --
-
Which has Higher Returns FTXH or FXH?
First Trust Health Care AlphaDEX Fund has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat First Trust Health Care AlphaDEX Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- -
What do Analysts Say About FTXH or FXH?
First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust Health Care AlphaDEX Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than First Trust Health Care AlphaDEX Fund, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than First Trust Health Care AlphaDEX Fund.
Company Buy Ratings Hold Ratings Sell Ratings FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 FXHFirst Trust Health Care AlphaDEX Fund0 0 0 -
Is FTXH or FXH More Risky?
First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, which suggesting that the stock is 33.633% less volatile than S&P 500. In comparison First Trust Health Care AlphaDEX Fund has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.872%.
-
Which is a Better Dividend Stock FTXH or FXH?
First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. First Trust Health Care AlphaDEX Fund offers a yield of 0.41% to investors and pays a quarterly dividend of $0.09 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. First Trust Health Care AlphaDEX Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FTXH or FXH?
First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than First Trust Health Care AlphaDEX Fund quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than First Trust Health Care AlphaDEX Fund's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while First Trust Health Care AlphaDEX Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for First Trust Health Care AlphaDEX Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -- FXHFirst Trust Health Care AlphaDEX Fund-- -- -- --
-
Which has Higher Returns FTXH or IHF?
iShares US Healthcare Providers ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat iShares US Healthcare Providers ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- IHFiShares US Healthcare Providers ETF-- -- -- -
What do Analysts Say About FTXH or IHF?
First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare Providers ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than iShares US Healthcare Providers ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than iShares US Healthcare Providers ETF.
Company Buy Ratings Hold Ratings Sell Ratings FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 IHFiShares US Healthcare Providers ETF0 0 0 -
Is FTXH or IHF More Risky?
First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, which suggesting that the stock is 33.633% less volatile than S&P 500. In comparison iShares US Healthcare Providers ETF has a beta of 0.786, suggesting its less volatile than the S&P 500 by 21.371%.
-
Which is a Better Dividend Stock FTXH or IHF?
First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. iShares US Healthcare Providers ETF offers a yield of 0.83% to investors and pays a quarterly dividend of $0.10 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. iShares US Healthcare Providers ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FTXH or IHF?
First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than iShares US Healthcare Providers ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than iShares US Healthcare Providers ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while iShares US Healthcare Providers ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for iShares US Healthcare Providers ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -- IHFiShares US Healthcare Providers ETF-- -- -- --
-
Which has Higher Returns FTXH or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About FTXH or PJP?
First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is FTXH or PJP More Risky?
First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, which suggesting that the stock is 33.633% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.587, suggesting its less volatile than the S&P 500 by 41.255%.
-
Which is a Better Dividend Stock FTXH or PJP?
First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. Invesco Pharmaceuticals ETF offers a yield of 0.96% to investors and pays a quarterly dividend of $0.22 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FTXH or PJP?
First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns FTXH or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to First Trust Nasdaq Pharmaceuticals ETF's net margin of --. First Trust Nasdaq Pharmaceuticals ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About FTXH or RSPH?
First Trust Nasdaq Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust Nasdaq Pharmaceuticals ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe First Trust Nasdaq Pharmaceuticals ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings FTXHFirst Trust Nasdaq Pharmaceuticals ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is FTXH or RSPH More Risky?
First Trust Nasdaq Pharmaceuticals ETF has a beta of 0.664, which suggesting that the stock is 33.633% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.871, suggesting its less volatile than the S&P 500 by 12.877%.
-
Which is a Better Dividend Stock FTXH or RSPH?
First Trust Nasdaq Pharmaceuticals ETF has a quarterly dividend of $0.13 per share corresponding to a yield of 1.65%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.69% to investors and pays a quarterly dividend of $0.06 per share. First Trust Nasdaq Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FTXH or RSPH?
First Trust Nasdaq Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. First Trust Nasdaq Pharmaceuticals ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, First Trust Nasdaq Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust Nasdaq Pharmaceuticals ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FTXHFirst Trust Nasdaq Pharmaceuticals ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is General Electric Stock Going Up?
General Electric Company, doing business these days as GE Aerospace…
Where Will Cisco Systems Stock Be in 10 Years?
Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…
Stock Ideas
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Sell
44
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
1
IONQ alert for Jan 9
IonQ [IONQ] is down 38.82% over the past day.
Sell
40
QMCO alert for Jan 9
Quantum [QMCO] is down 30.08% over the past day.
Sell
47
MATW alert for Jan 9
Matthews International [MATW] is up 14.21% over the past day.
